AmCad BioMed Corporation announced earnings results for the first quarter ended March 31, 2021. For the first quarter, the company announced sales was TWD 11.725 million compared to TWD 11.457 million a year ago. Operating loss was TWD 14.399 million compared to TWD 18.982 million a year ago. Net loss was TWD 11.052 million compared to TWD 15.937 million a year ago. Basic loss per share from continuing operations was TWD 0.21 compared to TWD 0.3 a year ago.